R Keiling

893 total citations
38 papers, 691 citations indexed

About

R Keiling is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, R Keiling has authored 38 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in R Keiling's work include Breast Cancer Treatment Studies (12 papers), Cancer Treatment and Pharmacology (11 papers) and Advanced Breast Cancer Therapies (4 papers). R Keiling is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Cancer Treatment and Pharmacology (11 papers) and Advanced Breast Cancer Therapies (4 papers). R Keiling collaborates with scholars based in France, Belgium and United Kingdom. R Keiling's co-authors include Pierre Kerbrat, P. Fumoleau, S Schraub, M. Namer, F.M. Delgado, T. Delozier, Alain Monnier, Marie-Thérèse Closon, E García-Giralt and C Vrousos and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

R Keiling

32 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Keiling France 11 362 218 155 152 118 38 691
T. Habeshaw United Kingdom 13 294 0.8× 96 0.4× 139 0.9× 78 0.5× 82 0.7× 28 516
M.H. Pejovic France 8 262 0.7× 230 1.1× 131 0.8× 211 1.4× 70 0.6× 12 640
C. Charra-Brunaud France 12 172 0.5× 340 1.6× 287 1.9× 229 1.5× 92 0.8× 39 769
Antonio De Leo Italy 17 228 0.6× 197 0.9× 164 1.1× 155 1.0× 71 0.6× 101 869
Eva Cristóbal Spain 15 276 0.8× 103 0.5× 66 0.4× 115 0.8× 65 0.6× 29 715
L. Kayitalire France 17 745 2.1× 67 0.3× 173 1.1× 160 1.1× 38 0.3× 40 1.1k
Farnaz Dadmanesh United States 13 197 0.5× 96 0.4× 147 0.9× 194 1.3× 44 0.4× 33 634
Gun Forsslund Sweden 13 183 0.5× 45 0.2× 123 0.8× 289 1.9× 54 0.5× 18 712
Mirka W. Jones United States 19 216 0.6× 704 3.2× 218 1.4× 138 0.9× 220 1.9× 33 1.2k
Ha Young Woo South Korea 12 118 0.3× 102 0.5× 108 0.7× 110 0.7× 71 0.6× 34 531

Countries citing papers authored by R Keiling

Since Specialization
Citations

This map shows the geographic impact of R Keiling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Keiling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Keiling more than expected).

Fields of papers citing papers by R Keiling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Keiling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Keiling. The network helps show where R Keiling may publish in the future.

Co-authorship network of co-authors of R Keiling

This figure shows the co-authorship network connecting the top 25 collaborators of R Keiling. A scholar is included among the top collaborators of R Keiling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Keiling. R Keiling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keiling, R, et al.. (2000). Dose-dependent hormonal effects of toremifene in postmenopausal breast cancer patients. Cancer Chemotherapy and Pharmacology. 45(5). 402–408. 6 indexed citations
2.
Limacher, Jean‐Marc, Brigitte Duclos, Dominique Levêque, et al.. (1995). 945 Phase I study of high dose 5-fluorouracil and folinic acid in weekly continuous infusion. European Journal of Cancer. 31. S197–S197. 2 indexed citations
3.
Roché, H., Pierre Kerbrat, Paul Rebattu, et al.. (1993). Phase II Trials of Tetrahydropyranyl-Adriamycin (Pirarubicin) on Renal and Colon Carcinoma, Melanoma, and Soft Tissue Sarcoma. American Journal of Clinical Oncology. 16(2). 137–139. 4 indexed citations
4.
Fumoleau, P., F.M. Delgado, T. Delozier, et al.. (1993). Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.. Journal of Clinical Oncology. 11(7). 1245–1252. 281 indexed citations
5.
Barillot, I., J.C. Horiot, Jean Cuisenier, et al.. (1993). Carcinoma of the cervical stump: A review of 213 cases. European Journal of Cancer. 29(9). 1231–1236. 20 indexed citations
6.
Schraub, S, Xu Sun, N Daly, et al.. (1992). Cervical and vaginal cancer associated with pessary use. Cancer. 69(10). 2505–2509. 28 indexed citations
7.
Hurteloup, P, P. Armand, Martina Schneider, et al.. (1989). Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. European Journal of Cancer and Clinical Oncology. 25(3). 423–428. 12 indexed citations
8.
Horiot, Jean-Claude, Jacques Pigneux, H Pourquier, et al.. (1988). Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines: A french cooperative study of 1383 cases. International Journal of Radiation Oncology*Biology*Physics. 14(4). 605–611. 133 indexed citations
9.
Schwartz, Lawrence B., et al.. (1988). Two partial remissions induced by an LHRH analogue in two postmenopausal women with metastatic breast cancer. Cancer. 62(12). 2498–2500. 13 indexed citations
10.
Caldéroli, H, et al.. (1987). [Ambulatory surgery in breast pathology. Analysis of 605 surgically treated cases].. PubMed. 113(4). 344–52. 1 indexed citations
11.
Jl, Misset, R Metz, R Keiling, et al.. (1987). Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. A study of short-term response rate.. PubMed. 7(4B). 737–40. 2 indexed citations
12.
Keiling, R, et al.. (1986). Die französische FAC-vs-FEC-Studie bei fortgeschrittenen Mammakarzinomen. Oncology Research and Treatment. 9(1). 8–10. 5 indexed citations
13.
Metz, R, Miguel Delgado‐Rodríguez, R Keiling, et al.. (1985). Mitoxantrone combined to vincristine, cyclophosphamide and fluorouracil in advanced breast cancer. Investigational New Drugs. 3(2). 163–166. 3 indexed citations
14.
Mathé, G, et al.. (1984). [An analog of gonadoliberin in the treatment of prostatic carcinoma].. PubMed. 13(23). 1443–5. 2 indexed citations
15.
Bellocq, J P, et al.. (1981). Quantification histologique des cellules néoplasiques dans les cancers du sein: confrontation avec les dosages des récepteurs hormonaux.. Comptes rendus des séances de la Société de biologie et de ses filiales. 175(1). 1 indexed citations
16.
Keiling, R, et al.. (1975). [Radiotherapy of malpighian cancers of the anus. Interstitial curietherapy using iridium 192 for anal canal epitheliomas].. PubMed. 54(8-9). 634–5. 2 indexed citations
17.
Keiling, R, et al.. (1973). [Role of radiology in the evaluation of the spread of rectal tumors].. PubMed. 54(2). 141–4.
18.
Keiling, R, et al.. (1971). Empreinte dentaire de contention pour irradiation des cancers de la tête et du cou.. 52(11). 1 indexed citations
19.
Keiling, R, et al.. (1955). [Thorotrast infection into the maxillary sinus: appearance of a malpighien epithelioma 15 years later].. PubMed. 42(5). 556–8. 5 indexed citations
20.
Keiling, R, et al.. (1954). [Anatomical and clinical study of 17 cases of reticulosarcoma of bone; Ewing's sarcoma; treatment; results].. PubMed. 41(1). 111–26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026